Avidity Partners Management LP Immatics N.V. Transaction History

Avidity Partners Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$9.78 - $13.49 $3.84 Million - $5.3 Million	393,100 New	393,100 $4.57 Million
Q2 2021 Aug 16, 2021	SELL	$10.43 - $12.81 $9.23 Million - $11.3 Million	-884,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.24 - $14.6 $9.06 Million - $12.9 Million	884,600 New	884,600 $9.92 Million

101

75.8M

238K

727K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $522M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.